That's just over a month away.
Biogen could struggle to maintain its market-leading position in multiple sclerosis over the next two years.
These otherwise esoteric assets are a big deal right now at Bank of America and Citigroup.
If President Trump cracks down on drug price inflation, these pharma and biotech offenders could be in big trouble.
The Apple supply chain has taken a hit in recent weeks, but these three companies need not worry.
Which of these two pioneering biotech companies are the best place for new money today?
Spinraza launch is off to a good start.
If Trump succeeds at lowering the corporate tax rate to 15%, as he's vowed to do, these four banks would see massive boosts to their bottom lines.
Here's a look at the media giants that dominate TV and movie production, and the income-investing profiles for their stocks.
Despite the fallout from the fake accounts scandal, Wells Fargo should be just fine over the long run.